NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/09/2026
Back to search
Official data from USPTO
ARACLON BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARACLON BIOTECH
ST13
US500000079160858Class
5, 42
Filing
79160858
Registration
4824486
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
02/10/2026
Trademark type
Word
Nice classes
5, 42
Filing date
09/24/2014
Registration date
10/06/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/09/2026
Last transaction
02/10/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Zaragoza, ES
Examiner
SCHIMPF, TIMOTHY O
Current location
Historical data usage
Holders and representatives
Holders
ARACLON BIOTECH, S.L.
ARACLON BIOTECH, S.L.
Representatives
Ashly I. Boesche Pattishall, McAuliffe, Newbury, Hilliard & Geralds
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; diagnostic testing materials for medical usediagnostic kits comprised of medical diagnostic reagents and assays for disease testing; diagnostic agents for pharmaceutical use; diagnostic reagents for medical use; pharmaceutical products for the nervous system and degenerative neurological diseases
Class 42
Research and development of vaccines and medicines; industrial research and analysis servicesblood analysis servicesbody composition analysis servicesDNA analysis services for scientific research purposes; medical and scientific laboratory testing services; chemical analysis; scientific and technological servicesscientific researchanalysis and testing in the field of immunoassays; scientific and technological servicesscientific research and product design in the field of immunoassays
Publications
History of USPTO decisions and trademark events.
42 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
02/09/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/08/2026
ES71
TEAS SECTION 71 RECEIVED
10/02/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/06/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/04/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
11/14/2021
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
11/14/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/04/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
05/26/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/06/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/27/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/12/2016
FIMP
FINAL DISPOSITION PROCESSED
05/12/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/06/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/21/2015
PUBO
PUBLISHED FOR OPPOSITION
07/21/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/01/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/15/2015
ALIE
ASSIGNED TO LIE
06/12/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/26/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
05/26/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/26/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
05/26/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/26/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/21/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2015
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/18/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
05/08/2015
RFNT
REFUSAL PROCESSED BY IB
03/27/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/09/2015
RFRR
REFUSAL PROCESSED BY MPU
03/09/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/06/2015
MAFR
APPLICATION FILING RECEIPT MAILED
03/06/2015
CNRT
NON-FINAL ACTION WRITTEN
03/05/2015
DOCK
ASSIGNED TO EXAMINER
03/02/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2015
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/27/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/26/2015
Continuous trademark protection
Get notified about every new filing that threatens ARACLON BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.